- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04507490
Analysis of Balance and Mobility for Parkinson Disease After Whole Body Vibration
August 7, 2020 updated by: Maria das Graças Rodrigues de Araújo, Universidade Federal de Pernambuco
Acute Effect of Whole Body Vibration of Different Frequencies on Balance and Functional Mobility of Patients With Parkinson: Crossover-type Controlled Clinical Trial
Parkinson's disease has innumerous motor symptoms that impacting on the functional level of the patient, such as impairment in functional mobility and balance .
Previous studies have already aimed to evaluate the effectiveness of whole body vibration, but without methodological criteria.
The use of whole body vibration may be an alternative for the treatment of Parkinson's disease.
Therefore, the objective of the study is to verify which frequency of vibration is able to improve the balance and mobility of patients with Parkinson's disease.
Study Overview
Detailed Description
After confirming the eligibility criteria, patients will be asked to sign the informed consent form.
Subsequently, they will be randomly allocated to three groups: (i) group 6 Hz: full body vibration (frequency 6 Hz, amplitude 4 mm, five cycles lasting 1 minutes and interval between cycles of 1 minute) , (ii) 25 Hz group: full body vibration (25 Hz frequency, 4 mm amplitude, five cycles lasting 1 minute and interval between 1 minute cycles) and (iii) sham group: The sham vibration will be performed with the platform disconnected.
Additionally, a sound device will be connected producing a noise similar to that of the connected platform for a time equivalent to that of the treatment protocol.
The patient will be instructed to position himself standing on the platform, with a semi knee flexion in order that the vibration wave does not propagate to the head.
The allocation will be made randomly among individuals, using a random sequence table generated by the website www.randomization.com.
There will be a washout time of at least one week between one intervention and another.
All evaluations took place inside the laboratory, which has all the equipment for the evaluation.
The evaluations will take place immediately before the intervention and immediately after.
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pernambuco
-
Paulista, Pernambuco, Brazil, 53433-665
- Recruiting
- Luis Mendes
-
Contact:
- Luis Mendes
- Phone Number: 81995082891
- Email: luuismendess@gmail.com
-
Sub-Investigator:
- Adriana Baltar
-
Sub-Investigator:
- Lavinia Salgado
-
Sub-Investigator:
- Bianca Maciel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
· Minimum score of the Montreal Cognitive Assessment (MoCA) (27 points);
- Regular antiparkinsonian pharmacological treatment;
- Staged from I to III on the modified Hoehn & Yahr scale.
Exclusion Criteria:
· Individuals with other neurological disorders, postural hypotension, vestibular, visual, cardiovascular or musculoskeletal disorders that affect the performance of the proposed tests;
- other associated neurological disease
- changes in medication in use for Parkinson's disease for at least sixty days before the start of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Whole body vibration 6 Hz
application of whole body vibration in the following parameters:frequency 6 Hz, amplitude 4 mm, five cycles lasting 1 minutes and interval between cycles of 1 minute
|
315/5000 application of whole body vibration with pre-established parameters for each group.
All patients will participate in all groups, an interval of at least one week.
They will be instructed to climb on the platform and to position a semi knee flexion and remain stationary during the vibration
|
Experimental: Whole body vibration 25 Hz
application of whole body vibration in the following parameters: 25 Hz frequency, 4 mm amplitude, five cycles lasting 1 minute and interval between 1 minute cycles
|
315/5000 application of whole body vibration with pre-established parameters for each group.
All patients will participate in all groups, an interval of at least one week.
They will be instructed to climb on the platform and to position a semi knee flexion and remain stationary during the vibration
|
Sham Comparator: Whole body vibration sham
application of whole body vibration in the following parameters: The sham vibration will be performed with the platform disconnected.
A sound device will be connected producing a noise similar to that of the connected platform for a time equivalent to that of the treatment protocol.
|
315/5000 application of whole body vibration with pre-established parameters for each group.
All patients will participate in all groups, an interval of at least one week.
They will be instructed to climb on the platform and to position a semi knee flexion and remain stationary during the vibration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Function mobility
Time Frame: Before (T0) and immediate after vibration (T1)
|
The evaluation of the functional mobility of individuals will be performed by the Timed Up and Go test.
It will analyze the time spent by the individual to get up from a chair with arms, walk for three meters and return to the chair
|
Before (T0) and immediate after vibration (T1)
|
Change in Static and dynamic balance
Time Frame: Before (T0) and immediate after vibration (T1)
|
The assessment of static and dynamic balance using the Biodex Balance System (BBS) tool, capable of evaluating the displacement of the center of mass in the anteroposterior and laterolateral axes on a circular platform that can oscillate up to 20 ° in all directions in the horizontal plane.
Static balance was performed using the Postural Stability Test, while dynamic balance was assessed using the Limits of Stability Test.
The MiniBest test was performed to assess dynamic balance.
The test consists of the application of 14 tasks that measure the patient's dynamic balance in different positions, through 14 items, with scores ranging from zero to two
|
Before (T0) and immediate after vibration (T1)
|
Change in static balance
Time Frame: Before (T0) and immediate after vibration (T1)
|
The indirect center of pressure (COP) was acquired by the baropodometric static platform (Sensor Medica).
The patient was instructed to position himself on the platform with his arms relaxed along his body, in the usual posture and looking towards the horizon, with a postural adaptation time of 30 seconds.
The collection started without being informed to the patient.
The averages of the three acquisitions of the following measures were analyzed of center of pressure
|
Before (T0) and immediate after vibration (T1)
|
Change in foot pressure
Time Frame: Before (T0) and immediate after vibration (T1)
|
The direct foot pressure was acquired by the baropodometric static platform (Sensor Medica).The patient was instructed to position himself on the platform with his arms relaxed along his body, in the usual posture and looking towards the horizon, with a postural adaptation time of 30 seconds.
The collection started without being informed to the patient.
The averages of the three acquisitions of the following measures were analyzed: (i) maximum pressure in the forefoot; (ii) maximum pressure in the midfoot and (iii) maximum pressure in the hindfoot.
|
Before (T0) and immediate after vibration (T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Cadence of gait
Time Frame: Before (T0) and immediate after vibration (T1)
|
The acquisition was made during the timed up and go, using the Wiva® Mob, an inertial sensor connected to the software via Bluetooth.
The inertial sensor will be placed on the patient's waist to measure gait cadence during the timed up ando go test
|
Before (T0) and immediate after vibration (T1)
|
Change in support phase of gait
Time Frame: Before (T0) and immediate after vibration (T1)
|
The acquisition was made during the timed up and go, using the Wiva® Mob, an inertial sensor connected to the software via Bluetooth.
The inertial sensor will be placed on the patient's waist to measure gait support phase during the timed up ando go test
|
Before (T0) and immediate after vibration (T1)
|
Change in swing phase of gait
Time Frame: Before (T0) and immediate after vibration (T1)
|
The acquisition was made during the timed up and go, using the Wiva® Mob, an inertial sensor connected to the software via Bluetooth.
The inertial sensor will be placed on the patient's waist to measure gait swing phase during the timed up ando go test
|
Before (T0) and immediate after vibration (T1)
|
Change in Risk of falls
Time Frame: Before (T0) and immediate after vibration (T1)
|
It was assessed using the "FallRisk" test of the Biodex balance System balance platform.
The BBS will show the general stability index (GSI).
In addition to the GSI, the BBS will show whether the patient is at risk of falls considering the age group
|
Before (T0) and immediate after vibration (T1)
|
Change in Functionality assessment
Time Frame: Before (T0) and immediate after vibration (T1)
|
It was carried out through session III of the UPDRS (Unified parkinson's disease rating scale), the responses vary between 0 and 4 with a total sum of the items of 108, so that higher values indicate a greater degree of dependence, while, lower values, greater degree of functionality
|
Before (T0) and immediate after vibration (T1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 15, 2020
Primary Completion (Anticipated)
October 15, 2020
Study Completion (Anticipated)
November 15, 2020
Study Registration Dates
First Submitted
August 5, 2020
First Submitted That Met QC Criteria
August 7, 2020
First Posted (Actual)
August 11, 2020
Study Record Updates
Last Update Posted (Actual)
August 11, 2020
Last Update Submitted That Met QC Criteria
August 7, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Whole_body_vibration_PD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Whole body vibration
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
The Hong Kong Polytechnic UniversityCompleted
-
The Hong Kong Polytechnic UniversityUnknown
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of the Balearic IslandsUnknown
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
University of SevilleAsociación de Enfermos de Parkinson de SevillaNot yet recruiting
-
University of CologneCompleted
-
Florida State UniversityCompleted